Stage IVB Rectal Cancer Completed Phase 1 Trials for Oxaliplatin (DB00526)

DBCOND0028589 (Stage IVB Rectal Cancer)Completed1 IdentifierTitlePurposeDrugs
NCT00060411A Phase I, Pharmacological, and Biological Study of OSI-774 in Combination With FOLFOX 4 (5-FU, Leucovorin, and Oxaliplatin) and Bevacizumab (Avastin) in Patients With Advanced Colorectal CancerTreatment
NCT00084643GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid TumorsTreatment
NCT01643499Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal MalignanciesTreatment
NCT02041481MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal CancerTreatment